ReP USP - Resultado da busca

Artigo de periodico
The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line (2017)
Borges, Kleiton S.; Andrade, Augusto F.; Silveira, Vanessa da Silva; Marco Antonio, David S.; Vasconcelos, Elton J.R.; Antonini, Sonir Roberto Rauber; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Anti-Cancer Drugs. Unidade: FMRP
Subjects: APOPTOSE, FÁRMACOS, ANTINEOPLÁSICOS, CARCINOMA, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Kleiton S. et al. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, v. 28, n. 6, p. 634-644, 2017Tradução . . Disponível em: https://doi.org/10.1097/cad.0000000000000504. Acesso em: 03 nov. 2024.
APA
Borges, K. S., Andrade, A. F., Silveira, V. da S., Marco Antonio, D. S., Vasconcelos, E. J. R., Antonini, S. R. R., et al. (2017). The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line. Anti-Cancer Drugs, 28( 6), 634-644. doi:10.1097/cad.0000000000000504
NLM
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Vancouver
Borges KS, Andrade AF, Silveira V da S, Marco Antonio DS, Vasconcelos EJR, Antonini SRR, Tone LG, Scrideli CA. The aurora kinase inhibitor AMG 900 increases apoptosis and induces chemosensitivity to anticancer drugs in the NCI-H295 adrenocortical carcinoma cell line [Internet]. Anti-Cancer Drugs. 2017 ; 28( 6): 634-644.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/cad.0000000000000504
Trabalho de evento-resumo periodico
Exportin7: a novel target to chemotherapy sensitivity in acute lymphoblastic leukemia cells lines (2012)
Silveira, Vanessa Silva; Borges, Kleiton Silva; Andrade, Augusto Faria; Suazo, Veridiana Kill; Cruzeiro, Gustavo Alencastro Veiga; Tone, Luiz Gonzaga; Scrideli, Carlos Alberto
Source: Pediatric Blood & Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: FÁRMACOS, LEUCEMIA (TRATAMENTO), QUIMIOTERAPIA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVEIRA, Vanessa Silva et al. Exportin7: a novel target to chemotherapy sensitivity in acute lymphoblastic leukemia cells lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2012
APA
Silveira, V. S., Borges, K. S., Andrade, A. F., Suazo, V. K., Cruzeiro, G. A. V., Tone, L. G., & Scrideli, C. A. (2012). Exportin7: a novel target to chemotherapy sensitivity in acute lymphoblastic leukemia cells lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Silveira VS, Borges KS, Andrade AF, Suazo VK, Cruzeiro GAV, Tone LG, Scrideli CA. Exportin7: a novel target to chemotherapy sensitivity in acute lymphoblastic leukemia cells lines. Pediatric Blood & Cancer. 2012 ; 59( 6): 1036.[citado 2024 nov. 03 ]
Vancouver
Silveira VS, Borges KS, Andrade AF, Suazo VK, Cruzeiro GAV, Tone LG, Scrideli CA. Exportin7: a novel target to chemotherapy sensitivity in acute lymphoblastic leukemia cells lines. Pediatric Blood & Cancer. 2012 ; 59( 6): 1036.[citado 2024 nov. 03 ]
Trabalho de evento-resumo periodico
DHMEQ inhibits in vitro migration and invasion in adult and pediatric glioblastoma cells (2012)
Delsin, Lara Elis Alberici; Roberto, Gabriela Molinari; Amichini, Maria Sol Brasseco; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS (TRATAMENTO), FÁRMACOS, CRIANÇAS, ADULTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DELSIN, Lara Elis Alberici et al. DHMEQ inhibits in vitro migration and invasion in adult and pediatric glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2012
APA
Delsin, L. E. A., Roberto, G. M., Amichini, M. S. B., Scrideli, C. A., & Tone, L. G. (2012). DHMEQ inhibits in vitro migration and invasion in adult and pediatric glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Delsin LEA, Roberto GM, Amichini MSB, Scrideli CA, Tone LG. DHMEQ inhibits in vitro migration and invasion in adult and pediatric glioblastoma cells. Pediatric Blood & Cancer. 2012 ; 59( 6): 1084.[citado 2024 nov. 03 ]
Vancouver
Delsin LEA, Roberto GM, Amichini MSB, Scrideli CA, Tone LG. DHMEQ inhibits in vitro migration and invasion in adult and pediatric glioblastoma cells. Pediatric Blood & Cancer. 2012 ; 59( 6): 1084.[citado 2024 nov. 03 ]
Trabalho de evento-resumo periodico
Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines (2011)
Ramos, Priscila; Castro-Gamero,Angel Mauricio; Andrade, Augusto Faria; Borges, Kleiton da Silva; Scrideli, Carlos Alberto; Umezawa, Kazuo; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS CEREBRAIS, CRIANÇAS, FÁRMACOS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Priscila et al. Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2011
APA
Ramos, P., Castro-Gamero, A. M., Andrade, A. F., Borges, K. da S., Scrideli, C. A., Umezawa, K., & Tone, L. G. (2011). Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Ramos P, Castro-Gamero AM, Andrade AF, Borges K da S, Scrideli CA, Umezawa K, Tone LG. Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 806.[citado 2024 nov. 03 ]
Vancouver
Ramos P, Castro-Gamero AM, Andrade AF, Borges K da S, Scrideli CA, Umezawa K, Tone LG. Evaluation of anti-neoplastic effects of inhibition of NFKB by DHMEQ (dehydroxymethylepoxyquinomicin) in pediatric medulloblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 806.[citado 2024 nov. 03 ]
Trabalho de evento-resumo periodico
Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? (2011)
Moreno, Daniel; Borges, Kleiton Silva; Gamero, Angel Mauricio Castro; Darrigo Júnior, Luiz Guilherme; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: CRIANÇAS, EXPRESSÃO GÊNICA, NEOPLASIAS CEREBRAIS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORENO, Daniel et al. Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ?. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2011
APA
Moreno, D., Borges, K. S., Gamero, A. M. C., Darrigo Júnior, L. G., Queiroz, R. G. de P., Scrideli, C. A., & Tone, L. G. (2011). Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Moreno D, Borges KS, Gamero AMC, Darrigo Júnior LG, Queiroz RG de P, Scrideli CA, Tone LG. Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? Pediatric Blood & Cancer. 2011 ; 57( 5): 805.[citado 2024 nov. 03 ]
Vancouver
Moreno D, Borges KS, Gamero AMC, Darrigo Júnior LG, Queiroz RG de P, Scrideli CA, Tone LG. Can zebularine be an altenative drug to tomozolomide resistant glioblastoma ? Pediatric Blood & Cancer. 2011 ; 57( 5): 805.[citado 2024 nov. 03 ]
Trabalho de evento-resumo periodico
Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells (2011)
Castro-Gamero, Angel Mauricio; Borges, Kleiton Silva; Moreno, Daniel Antunes; Carlotti Júnior, Carlos Gilberto; Scridelli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: NEOPLASIAS (TRATAMENTO), FÁRMACOS, PROTEÍNAS, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO-GAMERO, Angel Mauricio et al. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2011
APA
Castro-Gamero, A. M., Borges, K. S., Moreno, D. A., Carlotti Júnior, C. G., Scridelli, C. A., & Tone, L. G. (2011). Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 nov. 03 ]
Vancouver
Castro-Gamero AM, Borges KS, Moreno DA, Carlotti Júnior CG, Scridelli CA, Tone LG. Tetra-O-methyl nordihydroguaiaretic acid, a survivin inhibitor, increases growth arrest and apoptosis, reduces clonogenic capacity, and acts synergistically with temozolomide in glioblastoma cells. Pediatric Blood & Cancer. 2011 ; 57( 5): 718.[citado 2024 nov. 03 ]
Artigo de periodico
BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity (2011)
Morales, Andressa Gois; Brassesco, Maria Sol; Pezuk, Julia Alejandra; Oliveira, Jaqueline Carvalho de; Montaldi, Ana Paula; Hojo, Elza Tiemi Sakamoto; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Anti-Cancer Drugs. Unidades: IB, FFCLRP, FMRP
Subjects: OSTEOSSARCOMA (TRATAMENTO), FÁRMACOS, MITOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORALES, Andressa Gois et al. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, v. 22, n. 10, p. 995-1001, 2011Tradução . . Disponível em: https://doi.org/10.1097/cad.0b013e32834a16d4. Acesso em: 03 nov. 2024.
APA
Morales, A. G., Brassesco, M. S., Pezuk, J. A., Oliveira, J. C. de, Montaldi, A. P., Hojo, E. T. S., et al. (2011). BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity. Anti-Cancer Drugs, 22( 10), 995-1001. doi:10.1097/cad.0b013e32834a16d4
NLM
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Vancouver
Morales AG, Brassesco MS, Pezuk JA, Oliveira JC de, Montaldi AP, Hojo ETS, Scrideli CA, Tone LG. BI 2536-mediated PLK1 inhibition suppresses HOS and MG-63 osteosarcoma cell line growth and clonogenicity [Internet]. Anti-Cancer Drugs. 2011 ; 22( 10): 995-1001.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1097/cad.0b013e32834a16d4
Trabalho de evento-resumo periodico
Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines (2011)
Brassesco, Maria; Pezuk, Julia Alejandra; Morales, Andressa Gois; Oliveira, Jaqueline Carvalho de; Valera, Elvis Terci; Rego, Eduardo Magalhães; Carlotti Júnior, Carlos Gilberto; Umezawa, Kazuo; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga
Source: Pediatric Blood & Cancer. Conference titles: Annual Conference of the International Society of Paediatric Oncology (SIOP). Unidades: FMRP, IB
Subjects: APOPTOSE, CRIANÇAS, NEOPLASIAS CEREBRAIS (TRATAMENTO), FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRASSESCO, Maria et al. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 03 nov. 2024. , 2011
APA
Brassesco, M., Pezuk, J. A., Morales, A. G., Oliveira, J. C. de, Valera, E. T., Rego, E. M., et al. (2011). Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Brassesco M, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Rego EM, Carlotti Júnior CG, Umezawa K, Scrideli CA, Tone LG. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 803-804.[citado 2024 nov. 03 ]
Vancouver
Brassesco M, Pezuk JA, Morales AG, Oliveira JC de, Valera ET, Rego EM, Carlotti Júnior CG, Umezawa K, Scrideli CA, Tone LG. Dehydroxymethylepoxyquinomicin efficiently suppresses growth and induces apoptosis in pediatric and adult glioblastoma cell lines. Pediatric Blood & Cancer. 2011 ; 57( 5): 803-804.[citado 2024 nov. 03 ]
Artigo de periodico
Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment (2009)
Valera, Fabiana Cardoso Pereira; Queiroz, R.; Scrideli, Carlos Alberto; Tone, Luiz Gonzaga; Anselmo-Lima, Wilma Terezinha
Source: Clinical and Experimental Allergy. Unidade: FMRP
Subjects: PÓLIPOS NASAIS, CITOCINAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALERA, Fabiana Cardoso Pereira et al. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clinical and Experimental Allergy, v. 39, p. 81-88, 2009Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2222.2008.03144.x. Acesso em: 03 nov. 2024.
APA
Valera, F. C. P., Queiroz, R., Scrideli, C. A., Tone, L. G., & Anselmo-Lima, W. T. (2009). Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment. Clinical and Experimental Allergy, 39, 81-88. doi:10.1111/j.1365-2222.2008.03144.x
NLM
Valera FCP, Queiroz R, Scrideli CA, Tone LG, Anselmo-Lima WT. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment [Internet]. Clinical and Experimental Allergy. 2009 ; 39 81-88.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/j.1365-2222.2008.03144.x
Vancouver
Valera FCP, Queiroz R, Scrideli CA, Tone LG, Anselmo-Lima WT. Evaluating budesonide efficacy in nasal polyposis and predicting the resistance to treatment [Internet]. Clinical and Experimental Allergy. 2009 ; 39 81-88.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/j.1365-2222.2008.03144.x

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em